GreenLight Biosciences (GRNAW) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    GreenLight Biosciences

    NASDAQ: GRNAW · Real-Time Price · USD
    0.02
    -0.00 (-0.99%)
    At close: Jul 21, 2023, 6:10 PM

    GreenLight Biosciences Cash Flow Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -167.06M -112.31M
    Depreciation & Amortization
    		 8.08M 5.77M
    Stock-Based Compensation
    		 8.84M 1.99M
    Other Working Capital
    		 15.02M 6.83M
    Other Non-Cash Items
    		 5M 828K
    Deferred Income Tax
    		 n/a 1.36M
    Change in Working Capital
    		 8.41M 10.52M
    Operating Cash Flow
    		 -136.73M -91.83M
    Capital Expenditures
    		 -26.55M -15.15M
    Cash Acquisitions
    		 n/a n/a
    Purchase of Investments
    		 n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a
    Other Investing Acitivies
    		 37K 109K
    Investing Cash Flow
    		 -26.51M -15.04M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 200.85M 43.53M
    Financial Cash Flow
    		 200.85M 43.53M
    Net Cash Flow
    		 37.61M -63.34M
    Free Cash Flow
    		 -163.28M -106.98M

    Add to Watchlist